These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1532925)

  • 1. Characterization of IL-1 inhibitory factor released from human alveolar macrophages as IL-1 receptor antagonist.
    Takeuchi M; Nagai S; Nakada H; Aung H; Satake N; Kaneshima H; Izumi T
    Clin Exp Immunol; 1992 Apr; 88(1):181-7. PubMed ID: 1532925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The mechanism and specificity of IL-1 inhibitory factor released from human alveolar macrophages].
    Takeuchi M; Aung H; Nagai S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Aug; 30(8):1409-16. PubMed ID: 1434212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of the IL-1 beta and IL-1 receptor antagonist obtained from BALF macrophages in patients with interstitial lung diseases.
    Mikuniya T; Nagai S; Shimoji T; Takeuchi M; Morita K; Mio T; Satake N; Izumi T
    Sarcoidosis Vasc Diffuse Lung Dis; 1997 Mar; 14(1):39-45. PubMed ID: 9186988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages.
    Galve-de Rochemonteix B; Nicod LP; Junod AF; Dayer JM
    Am J Respir Cell Mol Biol; 1990 Oct; 3(4):355-61. PubMed ID: 2144978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proinflammatory or regulatory cytokines released from BALF macrophages of healthy smokers.
    Mikuniya T; Nagai S; Tsutsumi T; Morita K; Mio T; Satake N; Izumi T
    Respiration; 1999; 66(5):419-26. PubMed ID: 10516538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of IL-1 inhibitory activity as IL-1 receptor antagonist (IL-1ra) in vitro and kinetics of IL-1ra and IL-1 beta in experimental rabbit lung granuloma.
    Shigenaga T; Abe Y; Miyazaki E; Kita S; Tsuda T
    Exp Lung Res; 1995; 21(2):309-29. PubMed ID: 7774530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A urine inhibitor of interleukin 1 activity affects both interleukin 1 alpha and 1 beta but not tumor necrosis factor alpha.
    Seckinger P; Williamson K; Balavoine JF; Mach B; Mazzei G; Shaw A; Dayer JM
    J Immunol; 1987 Sep; 139(5):1541-5. PubMed ID: 3040855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-tumor interaction in ovarian cancer. Spontaneous release of tumor necrosis factor and interleukin-1 inhibitors by purified cell populations from human ovarian carcinoma in vitro.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Brightbill HD; Gatanaga M; DiSaia PJ; Granger GA; Gatanaga T
    Gynecol Oncol; 1994 Nov; 55(2):294-303. PubMed ID: 7959299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoic acid differentially regulates interleukin-1beta and interleukin-1 receptor antagonist production by human alveolar macrophages.
    Hashimoto S; Hayashi S; Yoshida S; Kujime K; Maruoka S; Matsumoto K; Gon Y; Koura T; Horie T
    Leuk Res; 1998 Nov; 22(11):1057-61. PubMed ID: 9783809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced interleukin-1 receptor antagonist release in mononuclear phagocytes.
    Marsh CB; Wewers MD
    Am J Respir Cell Mol Biol; 1994 May; 10(5):521-5. PubMed ID: 8179914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of IL-1 receptor antagonist by human in vitro-derived macrophages. Effects of lipopolysaccharide and granulocyte-macrophage colony-stimulating factor.
    Janson RW; Hance KR; Arend WP
    J Immunol; 1991 Dec; 147(12):4218-23. PubMed ID: 1836481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alveolar macrophages produce predominantly the 35-kD pro-forms of interleukin-1 alpha and interleukin-1 beta when stimulated with lipopolysaccharide.
    Janson RW; Hance KR; King TE
    Am J Respir Crit Care Med; 1995 May; 151(5):1613-20. PubMed ID: 7735621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effect of interleukin-13 on interleukin-1 receptor antagonist and proinflammatory cytokine production by human alveolar macrophages.
    Yanagawa H; Sone S; Haku T; Mizuno K; Yano S; Ohmoto Y; Ogura T
    Am J Respir Cell Mol Biol; 1995 Jan; 12(1):71-6. PubMed ID: 7811472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.
    McColl SR; Paquin R; Ménard C; Beaulieu AD
    J Exp Med; 1992 Aug; 176(2):593-8. PubMed ID: 1386877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.
    McIntyre KW; Stepan GJ; Kolinsky KD; Benjamin WR; Plocinski JM; Kaffka KL; Campen CA; Chizzonite RA; Kilian PL
    J Exp Med; 1991 Apr; 173(4):931-9. PubMed ID: 1826128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of inflammatory cytokine release from cultured alveolar macrophages from smokers and non-smokers by NO2.
    Dandrea T; Tu B; Blomberg A; Sandström T; Sköld M; Eklund A; Cotgreave I
    Hum Exp Toxicol; 1997 Oct; 16(10):577-88. PubMed ID: 9363475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human urine deoxyribonuclease increases endogenous thymidine in the mouse thymocyte interleukin 1 assay: an artificial interleukin-1 inhibitor.
    Svenson M; Bendtzen K
    Cytokine; 1989 Nov; 1(1):52-5. PubMed ID: 2491505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of human natural killer cells by lipopolysaccharide and generation of interleukin-1 alpha, beta, tumour necrosis factor and interleukin-6. Effect of IL-1 receptor antagonist.
    Conti P; Dempsey RA; Reale M; Barbacane RC; Panara MR; Bongrazio M; Mier JW
    Immunology; 1991 Aug; 73(4):450-6. PubMed ID: 1833315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic chemotherapy alters interleukin-1 beta and its receptor antagonist production by human alveolar macrophages in lung cancer patients.
    Haku T; Yanagawa H; Ohmoto Y; Takeuchi E; Yano S; Hanibuchi M; Nokihara H; Nishimura N; Sone S
    Oncol Res; 1996; 8(12):519-26. PubMed ID: 9160356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.